Clinical Trial Update: Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 multicenter randomized trial evaluating rivaroxaban on survival and development of portal hypertension complications in patients with cirrhosis. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Hypertension

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: David Garcia Cinca | Conditions: Cirrhosis | Phase 3 | Status: UNKNOWN